Actively Recruiting

Phase 4
Age: 18Years +
All Genders
NCT05681442

Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-02-27

600

Participants Needed

28

Research Sites

185 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Patients hospitalized in ICU with sepsis (infection with life-threatening organ dysfunction according to sepsis 3.0 definitions) or septic shock presumably due to MDR-GNB (multidrug resistant Gram-negative bacteria). The study will be a prospective multicentre, randomized, open-label comparative continuous vs. intermittent pivotal βL (Beta Lactamine) antibiotic infusion strategies and combination vs. monotherapy trial conducted with a 2X2 factorial design.

CONDITIONS

Official Title

Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults (≥ 18 years)
  • Hospital-acquired sepsis diagnosed within the last 24 hours
  • Hospitalized for more than 48 hours or discharged less than 48 hours ago
  • At least one risk factor for multidrug-resistant Gram-negative bacteria, including prior intravenous antibiotic use within 7 days (excluding certain antibiotics), prolonged hospital stay (≥ 15 days) within 3 months, prolonged mechanical ventilation (≥ 5 days) within 3 months, presence of indwelling devices, known colonization or infection with multidrug-resistant Gram-negative bacteria within 3 months, recent exposure to specific antibiotics within 3 months, recent travel to high-risk regions within 3 months, or urinary tract abnormalities in case of urinary infection
  • Appropriate bacteriological samples taken before starting antimicrobial therapy
  • Expected ICU stay longer than 3 days
Not Eligible

You will not qualify if you...

  • Known resistance to all proposed beta-lactams or to amikacin
  • Need for extrarenal treatment at inclusion
  • Known hypersensitivity to specified beta-lactam antibiotics or their excipients
  • Severe hypersensitivity to other beta-lactam antibiotics or their excipients
  • Known contraindications to aminoglycosides including hypersensitivity, advanced cirrhosis, myasthenia gravis, simultaneous aminoglycoside use, or association with ataluren
  • Non-complicated urinary tract infection not causing sepsis
  • Bone marrow transplant or chemotherapy-induced neutropenia
  • Infections requiring long-term antibiotic treatment over 8 days
  • Antibiotic treatment for new sepsis started before randomization exceeding specified doses or duration
  • Limitation of life support measures at screening
  • Participation in another interventional drug study
  • Pregnancy or breastfeeding
  • Legal restrictions such as being deprived of freedom or under legal protection
  • No affiliation to any health insurance system
  • Refusal to participate by patient or legal representative

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 28 locations

1

Médecine intensive - réanimation - CHU Amiens-Picardie

Amiens, France, 80054

Withdrawn

2

Réanimation polyvalente - CH d'Argenteuil - Hôpital Victor Dupuy

Argenteuil, France, 95100

Actively Recruiting

3

Réanimation polyvalente - CH Avignon

Avignon, France, 84000

Actively Recruiting

4

Médecine intensive - réanimation - CHU Bordeaux - Hôpital Pellegrin

Bordeaux, France, 33000

Actively Recruiting

5

Médecine intensive - réanimation - Ambroise Paré

Boulogne-Billancourt, France, 92100

Actively Recruiting

6

Médecine intensive - réanimation - CHU Gabriel Montpied

Clermont-Ferrand, France, 63003

Actively Recruiting

7

Anesthésie - Réanimation - Beaujon

Clichy, France, 92110

Actively Recruiting

8

Réanimation polyvalente/Surveillance continue - CH Sud Essonne-Etampes

Étampes, France, 91150

Actively Recruiting

9

Médecine intensive - réanimation-Centre Hospitalier Départemental Vendée

La Roche-sur-Yon, France, 85000

Actively Recruiting

10

Médecine intensive - réanimation - CHU Grenoble-Alpes Hôpital Michallon

La Tronche, France, 38700

Actively Recruiting

11

Réanimation polyvalente - CH de Versailles - Hôpital André Mignot

Le Chesnay, France, 78150

Actively Recruiting

12

Réanimation Médico Chirurgicale & USC - CH Le Mans

Le Mans, France, 72037

Actively Recruiting

13

Médecine Intensive Réanimation - Hôpital Croix Rousse

Lyon, France, 69004

Actively Recruiting

14

Médecine intensive - réanimation - HCL - Edouard Herriot

Lyon, France, 69437

Actively Recruiting

15

Réanimation polyvalente - CHR Metz-Thionville - Hôpital de Mercy

Metz, France, 57085

Actively Recruiting

16

Médecine intensive - réanimation - CHU Montpellier - Hôpital Lapeyronie

Montpellier, France, 34295

Actively Recruiting

17

Réanimation Chirurgicale - Saint Eloi

Montpellier, France, 34295

Actively Recruiting

18

Médecine Intensive Réanimation - Pasteur 2

Nice, France, 06100

Actively Recruiting

19

Médecine intensive - réanimation - CHU Nice - Hôpital Archet

Nice, France, 06202

Actively Recruiting

20

Médecine intensive - réanimation

Orléans, France, 45000

Actively Recruiting

21

Anesthésie - Réanimation - CHU Orléans

Orléans, France, 86000

Actively Recruiting

22

Médecine intensive et réanimation infectieuse - Bichat

Paris, France, 75018

Actively Recruiting

23

Réanimation chirurgicale - Bichat

Paris, France, 75018

Actively Recruiting

24

Institut Mutualiste du Montsouris

Paris, France

Actively Recruiting

25

Médecine intensive - réanimation - CHU Poitiers - Site de la Milétrie

Poitiers, France, 86000

Actively Recruiting

26

Médecine intensive et réanimation polyvalente 6 CHU de Reims - Hôpital Robert Debré

Reims, France, 51100

Withdrawn

27

Médecine intensive - réanimation-CH St Denis - Hôpital Delafontaine

Saint-Denis, France, 93200

Actively Recruiting

28

Médecine intensive - réanimation - CHU de Strasbourg - Nouvel Hôpital Civil

Strasbourg, France, 67091

Actively Recruiting

Loading map...

Research Team

J

Jean-François TIMSIT, MD-PhD

CONTACT

L

Lila BOUADMA, MD-PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here